These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2019711)

  • 21. Relationship between plasma fatty acid profile and antioxidant vitamins during normal pregnancy.
    Herrera E; Ortega H; Alvino G; Giovannini N; Amusquivar E; Cetin I
    Eur J Clin Nutr; 2004 Sep; 58(9):1231-8. PubMed ID: 15054438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feto-maternal transfusion in normal pregnancy and during delivery.
    Choavaratana R; Uer-Areewong S; Makanantakosol S
    J Med Assoc Thai; 1997 Feb; 80(2):96-100. PubMed ID: 9078693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic variability of extended interval tobramycin in burn patients.
    Bracco D; Landry C; Dubois MJ; Eggimann P
    Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue polypeptide specific antigen and soluble Fas during normal pregnancy and early life.
    Protonotariou E; Rizos D; Malamitsi-Puchner A; Sarandakou A; Botsis D
    In Vivo; 2006; 20(6B):901-5. PubMed ID: 17203787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced lopinavir exposure during pregnancy.
    Stek AM; Mirochnick M; Capparelli E; Best BM; Hu C; Burchett SK; Elgie C; Holland DT; Smith E; Tuomala R; Cotter A; Read JS
    AIDS; 2006 Oct; 20(15):1931-9. PubMed ID: 16988514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
    Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
    Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipid evolution during normal pregnancy].
    Kaabachi N; Fellah H; Abdelmoula J; Marrakchi O; Khrouf M; Mebazaa A
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(5):544-8. PubMed ID: 1401770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stereology of the myocardium in human fetus. Quantitative study of the structural changes in the last two trimesters of gestation].
    Vidal RX; Neves MC; Villar VC; Viana WN; Mandarim-de-Lacerda CA
    Arq Bras Cardiol; 1993 Apr; 60(4):221-4. PubMed ID: 8311728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the in vivo glycine fluxes of adolescent girls and adult women during early and late pregnancy.
    Thame M; Fletcher H; Baker T; Jahoor F
    Br J Nutr; 2010 Aug; 104(4):498-502. PubMed ID: 20334711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis].
    Akhtamova ZM; Khokholov LE; Dorokhov VV; Voropaeva SD
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):124-8. PubMed ID: 4004185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycemics: pharmacokinetic considerations during pregnancy.
    Klieger C; Pollex E; Kazmin A; Koren G
    Ther Drug Monit; 2009 Oct; 31(5):533-41. PubMed ID: 19730277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplacental passage of vancomycin during the second trimester of pregnancy.
    Bourget P; Fernandez H; Delouis C; Ribou F
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):908-11. PubMed ID: 1923224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ampicillin pharmacokinetics in pregnant women with acute pyelonephritis].
    Akhtamova ZM; Kholodov LE; Dorokhov VV; Gurtovoĭ BL
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):228-32. PubMed ID: 4015063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of tobramycin in the camel.
    Hadi AA; Wasfi IA; Gadir FA; Amiri MH; Bashir AK; Baggot JD
    J Vet Pharmacol Ther; 1994 Feb; 17(1):48-51. PubMed ID: 8196094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheep.
    Möller JC; Gilman JT; Kearns GL; Sussmane JB; Raszynski A; Wolfsdorf J; Reed MD
    Crit Care Med; 1992 Oct; 20(10):1454-8. PubMed ID: 1395668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of infusion systems on pharmacokinetic parameters of tobramycin in newborn infants.
    Nahata MC
    Chemotherapy; 1988; 34(5):361-6. PubMed ID: 3180903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tobramycin: maternal-fetal pharmacology.
    Bernard B; Garcia-Cazares SJ; Ballard CA; Thrupp LD; Mathies AW; Wehrle PF
    Antimicrob Agents Chemother; 1977 Apr; 11(4):688-94. PubMed ID: 856021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the kinetics of methaqualone during the late stage of pregnancy (author's transl)].
    Peiker G; Müller B; Nöschel H; Bonow A
    Pharmazie; 1979 Apr; 34(4):244-6. PubMed ID: 482333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.